Market Cap (In KRW)
362.9 Billion
Revenue (In KRW)
187.54 Billion
Net Income (In KRW)
-174 Million
Avg. Volume
52.19 Thousand
- Currency
- KRW
- Country
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 21250.0-48800.0
- PE
- -
- EPS
- -
- Beta Value
- 0.877
- ISIN
- KR7144510005
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Industry
- CEO
- Mr. Jong-Eun Park
- Employee Count
- -
- Website
- https://www.gccell.com
- Ipo Date
- 2016-06-23
- Details
- GC Cell Corporation develops cell therapy products. It also provides cell banking, sample inspection, clinical trial, and bio logistics services. The company was formerly known as Green Cross Lab Cell Corporation and changed its name to GC Cell Corporation in November 2021. GC Cell Corporation was founded in 2011 and is based in Yongin, South Korea.
More Stocks
-
LDSVF
-
HPMMHemp Naturals, Inc.
HPMM
-
GROREIT
-
GLOBAL-R
-
SHUNF
-
MFEC
-
WEWINWe Win Limited
WEWIN